Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer.
about
Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysisRetrospective analysis of treatment outcomes after postoperative chemoradiotherapy in advanced gastric cancerCytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trialsCatheterization-associated complications of intraperitoneal chemotherapy in advanced gastric cancer.p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases.The current state of stomach cancer surgery in the world.Therapeutic adenoviral gene transfer of a glycosyltransferase for prevention of peritoneal dissemination and metastasis of gastric cancer.Late-onset peritoneal recurrence of advanced gastric cancer 20 years after primary resection.A clinical and long-term follow-up study of peri-operative sequential triple therapy for gastric cancer.Analysis for the combination expression of CK20, FABP1 and MUC2 is sensitive for the prediction of peritoneal recurrence in gastric cancer.Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology.Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression.Peritoneal carcinomatosis
P2860
Q27004677-D6827F85-943F-412C-8B04-60DE96FD85C6Q33403352-1CA669B7-E244-4191-9361-7EE805021C4FQ34928467-4860FE6D-6916-4E93-B3CB-1FFBE9C6A453Q35002601-C2778CBF-A545-419B-B5E0-BF66983C0904Q36213882-AE600B6E-BC05-4EFA-97E2-937D5DB1B1A8Q36673635-D149DF3A-7E1C-4883-90DE-F8BC3FD8F4E9Q38765669-E078834E-1CF0-416A-A468-4690302DA08EQ38941340-316BF73F-3364-4D7B-9F3D-F51EF9611CE8Q38957336-65FAD24D-CD76-47BF-B501-671EC6E2FCBFQ39800221-98BF183B-E5D7-4E7D-AA40-D8E0AC3BD346Q43073067-1DF04364-273E-4A94-A5B2-55AB252C8B30Q43445784-EA7323FB-BD2D-4B09-B8CC-8BA36050CE4EQ47705262-51CE275D-5B48-4595-8EDF-C0F4B8677FC1Q50789452-0BD39922-661D-48F9-8F20-FA40008ED7AEQ58766340-006F8F0A-0C8C-41A0-B1B9-4D9A77ED6DAB
P2860
Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Strategies to decrease the inc ...... in resectable gastric cancer.
@en
type
label
Strategies to decrease the inc ...... in resectable gastric cancer.
@en
prefLabel
Strategies to decrease the inc ...... in resectable gastric cancer.
@en
P356
P1476
Strategies to decrease the inc ...... in resectable gastric cancer.
@en
P2093
Averbach AM
P2860
P304
P356
10.1002/BJS.1800830605
P407
P577
1996-06-01T00:00:00Z